WHAT RESEARCHERS STUDY
Primary research interest.
- BDNF and neurotrophic signalling
- Ischaemic-stroke research
- Learning and memory models
- Inflammatory and neurotransmitter pathways
NEW
COGNITIVE RESEARCH · IP-SEMAX-10
Semax
Neurotrophic signalling and experimental neuroprotection.
EVIDENCE SNAPSHOT · Limited regional human studies and preclinical data
Semax is a synthetic analogue related to an ACTH fragment. Research has examined BDNF-related signalling, ischaemic-stroke models, cognition and neuroprotective mechanisms.
10 mg / vial$75.00 CAD
FOR LABORATORY RESEARCH USE ONLYNot for human or animal consumption. No dosing or administration information is provided.
COMMUNITY DISCUSSION · ANECDOTAL
What people discuss online.
Reddit discussions most often mention focus, mental clarity, learning, mood and brain fog. Reports are subjective and sometimes include sleep disruption or no lasting benefit.
Community reports can be affected by placebo effects, concurrent products, training, diet, selection bias and inaccurate product identity.
EVIDENCE LIMITS
What the page does not claim.
Much of the clinical literature is older, small, regional and not readily generalizable. Semax is not approved by Health Canada or the FDA for cognitive enhancement.
SOURCES & FURTHER READING
Review the evidence directly.
Semax and BDNF signalling — PubMed ↗Acute stroke clinical study — PubMed ↗Community discussion — Reddit ↗Related catalog materials
View full catalog →
STRESS RESPONSE RESEARCH
Selank
Tuftsin-derived heptapeptide reference
10 mg / vial$75.00
